Comparing Surgery and Chemoradiotherapy for Head and Neck Cancer
Author Information
Author(s): Soo K-C, Tan E-H, Wee J, Lim D, Tai B-C, Khoo M-L, Goh C, Leong S-S, Tan T, Fong K-W, Lu P, See A, Machin D
Primary Institution: National Cancer Centre, Singapore
Hypothesis
Is concurrent chemoradiotherapy superior to surgery followed by adjuvant radiotherapy in treating stage III/IV nonmetastatic squamous cell head and neck cancer?
Conclusion
The study found no significant difference in disease-free survival between surgery followed by radiotherapy and concurrent chemoradiotherapy.
Supporting Evidence
- Patients with laryngeal/hypopharyngeal disease had a higher organ-preservation rate than others.
- The overall organ preservation rate was 45%.
- At a median follow-up of 6 years, the 3-year disease-free survival rates were 50% for surgery and 40% for chemoradiotherapy.
Takeaway
Doctors wanted to see if giving chemotherapy and radiation together was better than just doing surgery and then radiation. They found out that both ways worked about the same.
Methodology
Patients were randomized to receive either surgery followed by adjuvant radiotherapy or concurrent chemoradiotherapy.
Potential Biases
Patients' preferences for treatment may have influenced compliance and outcomes.
Limitations
The study faced slow patient recruitment and high noncompliance rates, which may affect the results.
Participant Demographics
Median age was 59 years, with 87% male and 80% Chinese.
Statistical Information
Confidence Interval
95% CI: 30–56%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website